Free Trial

PROCEPT BioRobotics (PRCT) Earnings Date, Estimates & Call Transcripts

PROCEPT BioRobotics logo
$88.94 +3.03 (+3.53%)
(As of 11/15/2024 08:54 PM ET)

PROCEPT BioRobotics Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 25Estimated
Actual EPS
(Oct. 28)
-$0.40 Beat By $0.09
Consensus EPS
(Oct. 28)
-$0.49

PROCEPT BioRobotics announced Q3 2024 earnings on October 28, 2024, reporting an EPS of -$0.40, which topped the consensus estimate of -$0.49 by $0.09. Quarterly revenue rose 66.4% year-over-year to $58.40 million, above analysts' expectations of $53.30 million. With a trailing EPS of -$1.95, PROCEPT BioRobotics' earnings are expected to grow next year, from ($1.74) to ($1.34) per share.

PRCT Upcoming Earnings

PROCEPT BioRobotics' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules.


Skip Charts & View Estimated and Actual Earnings Data

PRCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PROCEPT BioRobotics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.56-$0.49-$0.53
Q2 20242-$0.55-$0.53-$0.54
Q3 20242-$0.49-$0.48-$0.49
Q4 20242-$0.36-$0.34-$0.35
FY 20248-$1.96-$1.84-$1.90
Q1 20252-$0.38-$0.38-$0.38
Q2 20252-$0.37-$0.35-$0.36
Q3 20251-$0.29-$0.29-$0.29
Q4 20252-$0.21-$0.19-$0.20
FY 20257-$1.25-$1.21-$1.23
Q1 20261-$0.19-$0.19-$0.19
Q2 20261$0.20$0.20$0.20
Q3 20261$0.16$0.16$0.16

PROCEPT BioRobotics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/25/2025
(Estimated)
------- 
10/28/2024Q3 2024-$0.49-$0.40+$0.09-$0.40$53.30M$58.40M          
8/1/2024Q2 2024-$0.52-$0.50+$0.02-$0.50$50.10M$53.35M          
5/1/2024Q1 2024-$0.55-$0.51+$0.04-$0.51$41.58M$44.50M        
2/27/2024Q4 2023-$0.44-$0.54 -$0.10-$0.54$41.79M$43.58M        
11/1/2023Q3 2023-$0.53-$0.51+$0.02-$0.51$33.44M$35.10M        
7/27/2023Q2 2023-$0.57-$0.56+$0.01-$0.56$30.25M$33.10M    
Elon knows the truth, which is why they want him silenced (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration.

Watch this new documentary and you’ll discover what Elon knows,
4/27/2023Q1 2023-$0.59-$0.63 -$0.04-$0.63$24.32M$24.40M        
2/28/2023Q4 2022-$0.53-$0.56 -$0.03-$0.49$23.70M$23.78M    

PROCEPT BioRobotics Earnings - Frequently Asked Questions

PROCEPT BioRobotics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on PRCT's earnings history.

PROCEPT BioRobotics issued an update on its FY 2024 earnings guidance on Monday, October, 28th. The company issued revenue guidance of $222.5 million-$223.0 million, compared to the consensus revenue estimate of $217.1 million.

In the previous quarter, PROCEPT BioRobotics (NASDAQ:PRCT) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.09. Learn more on analysts' earnings estimate vs. PRCT's actual earnings.

The conference call for PROCEPT BioRobotics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for PROCEPT BioRobotics's latest earnings report can be read online.
Read Transcript

PROCEPT BioRobotics's earnings report can be found in their filing with the SEC.
View SEC filing

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded annual revenue of $136.19 million.

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded net income of -$105.90 million. PRCT has generated -$1.95 earnings per share over the last four quarters.

PROCEPT BioRobotics's earnings are expected to grow from ($1.74) per share to ($1.34) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:PRCT) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners